Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 1, 2000AIDS

A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: Selection of thymidine analog regimen therapy (START II)*

View Full Paper
Ask AI
Bookmark
Share

Authors

JEJoseph J. EronUniversity of North Carolina at Chapel HillRMRobert L. MurphyCenter for Global HealthDPDolores M. PetersonThe University of Texas Southwestern Medical Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Eron et al. (2000) studied this question.

synapsesocial.com/papers/6a13067f17455f99e89e7875https://doi.org/10.1097/00002030-200007280-00016
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Intra-Assay Performance Characteristics of Five Assays for Quantification of Human Immunodeficiency Virus Type 1 RNA in Plasma1998 · 52 citations
  2. 2The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadir1998 · 224 citations
  3. 3Virological and immunological responses to once-daily dosing of didanosine in combination with stavudine1999 · 26 citations
  4. 4Safety and Efficacy of Lamivudine-Zidovudine Combination Therapy in Antiretroviral-Naive Patients1996 · 175 citations
  5. 5Drug Susceptibility in HIV Infection After Viral Rebound in Patients Receiving Indinavir-Containing Regimens2000 · 305 citations